Impact of COVID-19 on ALS clinical research
Hosts: Jinsy A. Andrews, MD, MSc, Columbia University Medical Center and Timothy M. Miller, MD, PhD, Washington University (NEALS Co-Chairs)
Panelists: Richard Bedlack, MD, PhD, Duke ALS Clinic; James D. Berry, MD, MPH, Sean M. Healey & AMG Center for ALS at Mass General Hospital; Merit Cudkowicz, MD, Sean M. Healey & AMG Center for ALS at Mass General Hospital; Jonathan D. Glass, MD, Emory ALS Center; and Jeremy Shefner, MD, PhD, FAAN, Barrow Neurological Institute
As the COVID-19 situation continues to evolve, we know it is of particular concern for the ALS community, both for clinical care and research trials. To help address some of your questions and concerns, representatives from the NEALS leadership team hosted a webinar on March 27th on the impact of COVID-19 on ALS clinical research.